| abstract |
PROBLEM TO BE SOLVED: To provide a pharmaceutical composition containing a compound having an improved balance of S1P 5 receptor working activity with respect to S1P 1 receptor as an active ingredient, and S1P 5 intervening diseases (for example, neurodegenerative disease, multiple system atrophy). , Parkinson's disease). A pharmaceutical composition containing a compound represented by the general formula (V) or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier, specifically, for example, 1-[. ((3R) -6-Butoxy-3-methyl-3,4-dihydronaphthalene-2-yl) Methyl] Compounds such as azetidine-3-carboxylic acid. [Selection diagram] None |